Tower Research Capital (TRC)’s Cue Biopharma CUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,874
Closed -$3.53K 5302
2025
Q1
$3.53K Sell
3,874
-6,668
-63% -$6.07K ﹤0.01% 4394
2024
Q4
$11.5K Buy
10,542
+3,325
+46% +$3.62K ﹤0.01% 3706
2024
Q3
$5.46K Sell
7,217
-4,164
-37% -$3.15K ﹤0.01% 4267
2024
Q2
$14.1K Buy
11,381
+8,113
+248% +$10.1K ﹤0.01% 3963
2024
Q1
$6.18K Sell
3,268
-1,627
-33% -$3.08K ﹤0.01% 4418
2023
Q4
$12.9K Sell
4,895
-633
-11% -$1.67K ﹤0.01% 4002
2023
Q3
$12.7K Buy
5,528
+2,715
+97% +$6.24K ﹤0.01% 3870
2023
Q2
$10.3K Buy
+2,813
New +$10.3K ﹤0.01% 4117
2022
Q4
Sell
-2,906
Closed -$6K 5951
2022
Q3
$6K Sell
2,906
-2,616
-47% -$5.4K ﹤0.01% 5000
2022
Q2
$13K Buy
5,522
+2,249
+69% +$5.3K ﹤0.01% 4199
2022
Q1
$16K Buy
3,273
+900
+38% +$4.4K ﹤0.01% 3745
2021
Q4
$27K Sell
2,373
-414
-15% -$4.71K ﹤0.01% 3337
2021
Q3
$41K Sell
2,787
-2,344
-46% -$34.5K ﹤0.01% 3110
2021
Q2
$60K Buy
5,131
+3,845
+299% +$45K ﹤0.01% 2875
2021
Q1
$16K Sell
1,286
-2,063
-62% -$25.7K ﹤0.01% 4046
2020
Q4
$42K Buy
3,349
+2,168
+184% +$27.2K ﹤0.01% 3274
2020
Q3
$18K Sell
1,181
-6,469
-85% -$98.6K ﹤0.01% 3895
2020
Q2
$188K Buy
+7,650
New +$188K 0.01% 1838
2019
Q4
Sell
-501
Closed -$4K 3665
2019
Q3
$4K Buy
+501
New +$4K ﹤0.01% 3398
2019
Q2
Sell
-2,065
Closed -$16K 3778
2019
Q1
$16K Sell
2,065
-19,576
-90% -$152K ﹤0.01% 2392
2018
Q4
$102K Buy
21,641
+17,562
+431% +$82.8K 0.01% 952
2018
Q3
$37K Buy
4,079
+3,749
+1,136% +$34K ﹤0.01% 1948
2018
Q2
$4K Sell
330
-83
-20% -$1.01K ﹤0.01% 3118
2018
Q1
$6K Buy
+413
New +$6K ﹤0.01% 2649